Jade Biosciences, Inc. · NASDAQ:JBIO
Bellevue Group AG reported a 6.80% stake in Jade Biosciences, Inc. (Schedule 13G)
Event Dec 16, 2025 · Filed Feb 17, 2026
Bellevue Group AG reported a 6.80% stake in Jade Biosciences, Inc., 3,341,103 shares, as a passive investor on Dec 16, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 6.80%
- Shares
- 3,341,103
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Bellevue Group AG | 6.80% | 3,341,103 |
| Bellevue Asset Management AG | 6.80% | 3,341,103 |
Source
Related
- Jade Biosciences, Inc.
- Bellevue Group AG
- Jade Biosciences, Inc. shareholders
- Schedule 13G/A · Bellevue Group AG · Nov 16, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Nov 16, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Nov 16, 2026
- Schedule 13G/A · Paradigm Biocapital Advisors LP · Nov 16, 2026
- Schedule 13G · Franklin Templeton Inc · Oct 28, 2026
- Schedule 13G · BlackRock, Inc. · Oct 27, 2026